Company Filing History:
Years Active: 2004-2007
Title: Gary Samuel Coombs: Innovator in Serine Protease Inhibition
Introduction
Gary Samuel Coombs is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for serine protease activity. With a total of 2 patents, his work has implications for treating various medical conditions.
Latest Patents
Coombs' latest patents focus on inhibitors of serine protease activity of matriptase or MTSP1. The inventions provide compounds that inhibit this specific protease activity. Additionally, they include pharmaceutical compositions that utilize these compounds, along with methods for treating conditions that can be ameliorated by inhibiting matriptase or MTSP1. His work also encompasses recombinant serine protease domains and methods for screening compounds that inhibit the activity of matriptase or MTSP1.
Career Highlights
Throughout his career, Coombs has worked with prominent companies in the biotechnology sector, including Dendreon San Diego LLC and Dendreon Corporation. His experience in these organizations has contributed to his expertise in the field of protease inhibitors.
Collaborations
Coombs has collaborated with notable colleagues such as Joseph Edward Semple and John Eugene Reiner. These partnerships have likely enhanced his research and development efforts in the area of serine protease inhibition.
Conclusion
Gary Samuel Coombs is a distinguished inventor whose work in serine protease inhibitors has the potential to impact medical treatments significantly. His contributions to the field are marked by his innovative patents and collaborations with other experts.